Status:
COMPLETED
Enoxaparin as Treatment for Vulvodynia
Lead Sponsor:
Western Galilee Hospital-Nahariya
Conditions:
Vulvodynia
Eligibility:
FEMALE
19-50 years
Phase:
PHASE2
Brief Summary
The investigators hypothesize that injections of Low molecular weight heparin (LMWH) \[enoxaparin\] will reduce pain in women with vulvodynia.
Eligibility Criteria
Inclusion
- women with vulvodynia
Exclusion
- women without vulvodynia
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00874484
Start Date
March 1 2009
End Date
May 1 2011
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Galilee Hospital- Nahariya
Nahariya, Israel, 22100